Literature DB >> 20427010

Pathogenesis of acanthamoeba keratitis.

Noorjahan Panjwani1.   

Abstract

Acanthamoeba keratitis (AK) is a serious infection of the cornea. At present, diagnosis of the disease is not straightforward and treatment is very demanding. While contact lens wear is the leading risk factor for A K, Acanthamoeba parasites are increasingly recognized as an important cause of keratitis in non-contact lens wearers. The first critical step in the pathogenesis of infection is the adhesion of the microbe to the surface of the host tissues. Acanthamoebae express a major virulence protein, the mannose-binding protein (MBP), which mediates the adhesion of amoebae to the surface of the cornea. The MBP is a transmembrane protein with characteristics of a typical cell surface receptor. Subsequent to the MBP-mediated adhesion to host cells, the amoebae produce a contact-dependent metalloproteinase and several contact-independent serine proteinases. These proteinases work in concert to produce a potent cytopathic effect (CPE ) involving killing of the host cells, degradation of epithelial basement membrane and underlying stromal matrix, and penetration into the deeper layers of the cornea. In the hamster animal model, oral immunization with the recombinant MBP protects against AK, and this protection is associated with an increased level of anti-MBP IgA in tears of protected animals. Normal human tear fluid contains IgA antibodies against Acanthamoeba MBP that is likely to provide protection by inhibiting the adhesion of parasites to host cells. Indeed, in in vitro CPE assays, even a low concentration of tears (10 microL of undiluted tears per milliliter of media) almost completely inhibits Acanthamoeba-induced CPE . In addition to adherence-inhibiting, IgA-mediated protection, human tears also contain IgA-independent factors that provide protection against Acanthamoeba-induced CPE by inhibiting the activity of cytotoxic proteinases. Characterization of the CPE-inhibitory factors of human tears should lead to a better understanding of the mechanism by which the tissues of the host resist the infection and also help decode circumstances that predispose to Acanthamoeba infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427010      PMCID: PMC3072032          DOI: 10.1016/s1542-0124(12)70071-x

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  90 in total

1.  The phosphotyrosine binding-like domain of talin activates integrins.

Authors:  David A Calderwood; Boxu Yan; Jose M de Pereda; Begoña García Alvarez; Yosuke Fujioka; Robert C Liddington; Mark H Ginsberg
Journal:  J Biol Chem       Date:  2002-04-03       Impact factor: 5.157

Review 2.  Glycosylation and the complement system.

Authors:  Gayle E Ritchie; Beryl E Moffatt; Robert B Sim; B Paul Morgan; Raymond A Dwek; Pauline M Rudd
Journal:  Chem Rev       Date:  2002-02       Impact factor: 60.622

Review 3.  Encystation in parasitic protozoa.

Authors:  D Eichinger
Journal:  Curr Opin Microbiol       Date:  2001-08       Impact factor: 7.934

Review 4.  Role of tear anti-acanthamoeba IgA in Acanthamoeba keratitis.

Authors:  J Y Niederkorn; H Alizadeh; H Leher; S Apte; S El Agha; L Ling; M Hurt; K Howard; H D Cavanagh; J P McCulley
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

5.  Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels.

Authors:  Neil A Turner; David J O'Regan; Stephen G Ball; Karen E Porter
Journal:  FASEB J       Date:  2005-02-23       Impact factor: 5.191

6.  Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis.

Authors:  H Alizadeh; S Apte; M S El-Agha; L Li; M Hurt; K Howard; H D Cavanagh; J P McCulley; J Y Niederkorn
Journal:  Cornea       Date:  2001-08       Impact factor: 2.651

Review 7.  The role of the innate and adaptive immune responses in Acanthamoeba keratitis.

Authors:  Jerry Y Niederkorn
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2002       Impact factor: 4.291

8.  Role of contact lens wear, bacterial flora, and mannose-induced pathogenic protease in the pathogenesis of amoebic keratitis.

Authors:  Hassan Alizadeh; Sudha Neelam; Michael Hurt; Jerry Y Niederkorn
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 9.  The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica.

Authors:  William A Petri; Rashidul Haque; Barbara J Mann
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

10.  [Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].

Authors:  Rodrigo Donoso; Juan José Mura; Mauricio López
Journal:  Rev Med Chil       Date:  2002-04       Impact factor: 0.553

View more
  45 in total

1.  Cytotoxic activity and degradation patterns of structural proteins by corneal isolates of Acanthamoeba spp.

Authors:  Viviane Peracini Sant'ana; Linda Christian Carrijo-Carvalho; Annette Silva Foronda; Ana Marisa Chudzinski-Tavassi; Denise de Freitas; Fábio Ramos Souza de Carvalho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-27       Impact factor: 3.117

2.  Sensitivity of Enzymatic Toxins from Corneal Isolate of Acanthamoeba Protozoan to Physicochemical Parameters.

Authors:  Viviane P Sant'Ana; Annette S Foronda; Denise de Freitas; Linda C Carrijo-Carvalho; Fábio Ramos de Souza Carvalho
Journal:  Curr Microbiol       Date:  2017-07-28       Impact factor: 2.188

Review 3.  The Development of Drugs against Acanthamoeba Infections.

Authors:  Ruqaiyyah Siddiqui; Yousuf Aqeel; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

4.  Photochemotherapeutic strategy against Acanthamoeba infections.

Authors:  Yousuf Aqeel; Ruqaiyyah Siddiqui; Ayaz Anwar; Muhammad Raza Shah; Shahrukh Khoja; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

5.  [Acanthamoeba keratitis].

Authors:  N Szentmáry; L Daas; P Matoula; S Goebels; B Seitz
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

6.  Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp.

Authors:  Zubeyda Akin Polat; Gulderen Karakus
Journal:  Parasitol Res       Date:  2012-10-10       Impact factor: 2.289

7.  Inhibitory effect of host ocular microenvironmental factors on chlorhexidine digluconate activity.

Authors:  Chun-Hsien Chen; Yu-Jen Wang; Jian-Ming Huang; Fu-Chin Huang; Wei-Chen Lin
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

8.  Role of phospholipase A₂ (PLA₂) inhibitors in attenuating apoptosis of the corneal epithelial cells and mitigation of Acanthamoeba keratitis.

Authors:  Trivendra Tripathi; Mahshid Abdi; Hassan Alizadeh
Journal:  Exp Eye Res       Date:  2013-06-20       Impact factor: 3.467

9.  Role of protease-activated receptors 2 (PAR2) in ocular infections and inflammation.

Authors:  Trivendra Tripathi; Hassan Alizadeh
Journal:  Receptors Clin Investig       Date:  2014

10.  Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.

Authors:  C M Martín-Navarro; A López-Arencibia; F Arnalich-Montiel; B Valladares; J E Piñero; J Lorenzo-Morales
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.